IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 123 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $34,592,303 | 27.53% |
| RTW INVESTMENTS, LP | 6,029,633 | $361,536,795 | 6.88% |
| Paradigm Biocapital Advisors LP | 1,270,124 | $76,156,635 | 5.88% |
| Rock Springs Capital Management LP | 3,028,410 | $181,583,464 | 4.32% |
| Logos Global Management LP | 500,000 | $29,980,000 | 4.08% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $24,319,776 | 3.58% |
| GREAT POINT PARTNERS LLC | 297,082 | $17,813,037 | 3.49% |
| Eschler Asset Management LLP | 34,000 | $2,038,640 | 2.89% |
| COWEN AND COMPANY, LLC | 460,036 | $27,583,758 | 2.29% |
| HighVista Strategies LLC | 44,094 | $2,643,876 | 1.21% |
| Avidity Partners Management LP | 575,000 | $34,477,000 | 1.20% |
| BRAIDWELL LP | 468,027 | $28,062,899 | 0.92% |
| GENERAL ATLANTIC, L.P. | 950,000 | $56,962,000 | 0.90% |
| Baker Brothers Advisors | 2,520,731 | $151,143,031 | 0.88% |
| Samsara BioCapital, LLC | 80,963 | $4,854,541 | 0.85% |
| Pier Capital, LLC | 68,287 | $4,094,489 | 0.59% |
| Rhenman & Partners Asset Management AB | 89,278 | $5,353,109 | 0.56% |
| Dalton Investments, Inc. | 10,000 | $599,600 | 0.51% |
| ARMISTICE CAPITAL, LLC | 428,000 | $25,662,880 | 0.37% |
| Virtus ETF Advisers LLC | 5,949 | $356,702 | 0.21% |
External links
This page lists IMMUNOCORE HLDGS PLC's shareholders in Q2 2023. To view IMMUNOCORE HLDGS PLC's shareholder history, click here.